Caixin
BUSINESS & TECH

U.S. Approves China-Made Biological HIV Drug

Trogarzo's success marks the first approval for a new biologically-based drug by the FDA this year. Photo: VCG
Trogarzo's success marks the first approval for a new biologically-based drug by the FDA this year. Photo: VCG

A biologically-based alternative HIV treatment developed in Taiwan and manufactured in China has won approval from the U.S. Food and Drug Administration (FDA), becoming the first such made-in-China drug to receive such approval, its producers said on Wednesday.

Ibalizumab-uiyk, which also goes by the name of Trogarzo, is a new option for people who have tried more conventional drugs without success to treat the virus that causes AIDS due to factors like resistance to those drugs, according to Taiwan-based TaiMed Biologics, which developed the drug and is producing it on the Chinese mainland with partner WuXi Biologics.

ladingImg
You've accessed an article available only to subscribers
Try 4 weeks for $0.99
SUBSCRIBE
Share this article
Open WeChat and scan the QR code
Copyright © 2018 Caixin Global Limited. All Rights Reserved.